Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4350)
All Articles published online
|
May 28, 2011 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: Fad or future of liver disease. World J Gastroenterol 2011; 17(20): 2536-2542 [PMID: 21633658 DOI: 10.3748/wjg.v17.i20.2536] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i20/2536.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Peng-Sheng Yi, Ming Zhang, Ming-Qing Xu. Role of microRNA in liver regeneration. Hepatobiliary & Pancreatic Diseases International 2016; 15(2): 141 doi: 10.1016/S1499-3872(15)60036-4
|
| 3 |
Yihua Bei, Yang Song, Fei Wang, Jasmina Dimitrova-Shumkovska, Yang Xiang, Yingying Zhao, Jingqi Liu, Junjie Xiao, Changqing Yang. miR-382 targeting PTEN-Akt axis promotes liver regeneration. Oncotarget 2016; 7(2): 1584 doi: 10.18632/oncotarget.6444
|
| 4 |
Yi-Hsun Chen, Chien-Chao Chiu, Shao-Wen Hung, Wen-Ching Huang, Yen-Peng Lee, Ju-Yun Liu, Yen-Te Huang, Ter-Hsin Chen, Hsiao-Li Chuang. Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism. Nutrition Research 2019; 69: 20 doi: 10.1016/j.nutres.2019.07.001
|
| 5 |
Gyongyi Szabo, Peter Sarnow, Shashi Bala. MicroRNA silencing and the development of novel therapies for liver disease. Journal of Hepatology 2012; 57(2): 462 doi: 10.1016/j.jhep.2012.01.030
|
| 6 |
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, Jinho Yang, Yoon-Keun Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Jae-Yong Chung, Joo-Youn Cho. Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30349-1
|
| 7 |
Xinli Li, Fuzhi Lian, Chun Liu, Kang-Quan Hu, Xiang-Dong Wang. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice. Scientific Reports 2015; 5(1) doi: 10.1038/srep16774
|
| 8 |
|
| 9 |
Nihar Shah, James E. Nelson, Kris V. Kowdley. MicroRNAs in Liver Disease: Bench to Bedside. Journal of Clinical and Experimental Hepatology 2013; 3(3): 231 doi: 10.1016/j.jceh.2013.09.001
|
| 10 |
Joo Lee, Simonetta Friso, Sang-Woon Choi. Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition. Nutrients 2014; 6(8): 3303 doi: 10.3390/nu6083303
|
| 11 |
Elizabeth Brandon-Warner, Nicole A. Feilen, Catherine R. Culberson, Conroy O. Field, Andrew S. deLemos, Mark W. Russo, Laura W. Schrum. Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury. Alcoholism: Clinical and Experimental Research 2016; 40(7): 1430 doi: 10.1111/acer.13116
|
| 12 |
Hyo Jung Cho, Jai Keun Kim, Ji Sun Nam, Hee Jung Wang, Jei Hee Lee, Bong Wan Kim, Soon Sun Kim, Choong Kyun Noh, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. Clinical Biochemistry 2015; 48(16-17): 1073 doi: 10.1016/j.clinbiochem.2015.06.019
|
| 13 |
Dong Zhao, Yi Luo, Yun Xia, Jian-Jun Zhang, Qiang Xia. MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis. Digestive Diseases and Sciences 2017; 62(3): 689 doi: 10.1007/s10620-016-4411-z
|
| 14 |
Sara Tomaselli, Nadia Panera, Angela Gallo, Anna Alisi. Circulating miRNA profiling to identify biomarkers of dysmetabolism. Biomarkers in Medicine 2012; 6(6): 729 doi: 10.2217/bmm.12.91
|
| 15 |
Feng Qi, Jiang-Feng Hu, Bao-Hai Liu, Chao-Qun Wu, Hong-Yu Yu, Ding-Kang Yao, Liang Zhu. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1. World Journal of Gastroenterology 2015; 21(34): 9900-9915 doi: 10.3748/wjg.v21.i34.9900
|
| 16 |
P. P. Gimadiev, A. R. Niiazov, V. E. Mukhin, P. P. Ogurtsov. THE DIAGNOSTIC IMPORTANCE OF CIRCULATING MICRORNA FOR NON-ALCOHOLIC FATTY LIVER DISEASE: LITERATURE REVIEW. Russian Clinical Laboratory Diagnostics 2019; 64(12): 723 doi: 10.18821/0869-2084-2019-64-12-723-729
|
| 17 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 731 doi: 10.1016/B978-1-63067-036-8.00028-7
|
| 18 |
Ashley M. Miller, Derek S. Gilchrist, Jagtar Nijjar, Elisa Araldi, Cristina M. Ramirez, Christopher A. Lavery, Carlos Fernández-Hernando, Iain B. McInnes, Mariola Kurowska-Stolarska, Massimo Federici. MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice. PLoS ONE 2013; 8(8): e72324 doi: 10.1371/journal.pone.0072324
|
| 19 |
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
|
| 20 |
Constance Mobley, Ali Zarrinpar. Transplantation of the Liver. 2015; : 40 doi: 10.1016/B978-1-4557-0268-8.00003-8
|
| 21 |
Anthony Virtue, Candice Johnson, Jahaira Lopez-Pastraña, Ying Shao, Hangfei Fu, Xinyuan Li, Ya-Feng Li, Ying Yin, Jietang Mai, Victor Rizzo, Michael Tordoff, Zsolt Bagi, Huimin Shan, Xiaohua Jiang, Hong Wang, Xiao-Feng Yang. MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease. Journal of Biological Chemistry 2017; 292(4): 1267 doi: 10.1074/jbc.M116.739839
|
| 22 |
Miriam Capri, Fabiola Olivieri, Catia Lanzarini, Daniel Remondini, Vincenzo Borelli, Raffaella Lazzarini, Laura Graciotti, Maria Cristina Albertini, Elena Bellavista, Aurelia Santoro, Fiammetta Biondi, Enrico Tagliafico, Elena Tenedini, Cristina Morsiani, Grazia Pizza, Francesco Vasuri, Antonietta D'Errico, Alessandro Dazzi, Sara Pellegrini, Alessandra Magenta, Marco D'Agostino, Maurizio C. Capogrossi, Matteo Cescon, Maria Rita Rippo, Antonio Domenico Procopio, Claudio Franceschi, Gian Luca Grazi. Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants. Aging Cell 2017; 16(2): 262 doi: 10.1111/acel.12549
|
| 23 |
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_37-1
|
| 24 |
Ulas Emre Akbulut. Biomarkers in Nutrition. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 1 doi: 10.1007/978-3-030-81304-8_30-1
|
| 25 |
Mónika Gyugos, Gábor Lendvai, István Kenessey, Krisztina Schlachter, Judit Halász, Péter Nagy, Miklós Garami, Zsuzsa Jakab, Zsuzsa Schaff, András Kiss. microRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Archiv 2014; 464(4): 419 doi: 10.1007/s00428-014-1549-y
|
| 26 |
Iain H McKillop, Laura W Schrum, Kyle J Thompson. Role of alcohol in the development and progression of hepatocellular carcinoma. Hepatic Oncology 2016; 3(1): 29 doi: 10.2217/hep.15.40
|
| 27 |
Jiexia Ding, Meng Li, Xingyong Wan, Xi Jin, Shaohua Chen, Chaohui Yu, Youming Li. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease. Scientific Reports 2015; 5(1) doi: 10.1038/srep13729
|
| 28 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 85 doi: 10.1016/B978-1-63067-036-8.00004-4
|
| 29 |
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/4168380
|
| 30 |
Nadia Fattahi, Lena Gorgannezhad, Shabnam Farkhonde Masoule, Niloofar Babanejad, Ali Ramazani, Mohammad Raoufi, Elham Sharifikolouei, Alireza Foroumadi, Mehdi Khoobi. PEI-based functional materials: Fabrication techniques, properties, and biomedical applications. Advances in Colloid and Interface Science 2024; 325: 103119 doi: 10.1016/j.cis.2024.103119
|
| 31 |
Feifei Wang, Ge Song, Min Liu, Xin Li, Hua Tang. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Letters 2011; 585(20): 3263 doi: 10.1016/j.febslet.2011.08.052
|
| 32 |
Fanyin Meng, Shannon S. Glaser, Heather Francis, Fuquan Yang, Yuyan Han, Allison Stokes, Dustin Staloch, Jennifer McCarra, Jingang Liu, Julie Venter, Haiying Zhao, Xiuping Liu, Taylor Francis, Scott Swendsen, Chang-Gong Liu, Hidekazu Tsukamoto, Gianfranco Alpini. Epigenetic Regulation of miR-34a Expression in Alcoholic Liver Injury. The American Journal of Pathology 2012; 181(3): 804 doi: 10.1016/j.ajpath.2012.06.010
|
| 33 |
Cinta Bladé, Laura Baselga‐Escudero, Maria Josepa Salvadó, Anna Arola‐Arnal. miRNAs, polyphenols, and chronic disease. Molecular Nutrition & Food Research 2013; 57(1): 58 doi: 10.1002/mnfr.201200454
|
| 34 |
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. International Journal of Molecular Sciences 2021; 22(14): 7716 doi: 10.3390/ijms22147716
|
| 35 |
Ulas Emre Akbulut. Biomarkers in Nutrition. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 517 doi: 10.1007/978-3-031-07389-2_30
|
| 36 |
Kimberley D. Bruce, Felino R. Cagampang. Parental Obesity: Intergenerational Programming and Consequences. 2016; : 255 doi: 10.1007/978-1-4939-6386-7_12
|
| 37 |
Zehra Oksuz, Mehmet Sami Serin, Engin Kaplan, Aylin Dogen, Seda Tezcan, Gonul Aslan, Gurol Emekdas, Orhan Sezgin, Engin Altintas, Eyup Naci Tiftik. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Molecular Biology Reports 2015; 42(3): 713 doi: 10.1007/s11033-014-3819-9
|
| 38 |
SHIMA MIMURA, HISAKAZU IWAMA, KIYOHITO KATO, KEI NOMURA, MITSUYOSHI KOBAYASHI, HIROHITO YONEYAMA, HISAAKI MIYOSHI, JOJI TANI, ASAHIRO MORISHITA, TAKASHI HIMOTO, AKIHIRO DEGUCHI, TAKAKO NOMURA, TEPPEI SAKAMOTO, KOJI FUJITA, EMIKO MAEDA, KUNIHIKO IZUISHI, KEIICHI OKANO, YASUYUKI SUZUKI, TSUTOMU MASAKI. Profile of microRNAs associated with aging in rat liver. International Journal of Molecular Medicine 2014; 34(4): 1065 doi: 10.3892/ijmm.2014.1892
|
| 39 |
Yueh Chien, Yuh-Lih Chang, Hsin-Yang Li, Mikael Larsson, Wai-Wah Wu, Chian-Shiu Chien, Chien-Ying Wang, Pen-Yuan Chu, Kuan-Hsuan Chen, Wen-Liang Lo, Shih-Hwa Chiou, Yuan-Tzu Lan, Teh-Ia Huo, Shou-Dong Lee, Pin-I Huang. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: Accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model. Acta Biomaterialia 2015; 13: 228 doi: 10.1016/j.actbio.2014.11.018
|
| 40 |
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytes. Journal of Cellular Physiology 2020; 235(2): 880 doi: 10.1002/jcp.29002
|
| 41 |
Michela Bulfoni, Riccardo Pravisani, Emiliano Dalla, Daniela Cesselli, Masaaki Hidaka, Carla Di Loreto, Susumu Eguchi, Umberto Baccarani. miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation. Journal of Medical Virology 2021; 93(8): 4992 doi: 10.1002/jmv.26999
|
| 42 |
Aditi Bhattacharya. Epigenetics in Organ Specific Disorders. 2023; : 497 doi: 10.1016/B978-0-12-823931-5.00005-0
|
| 43 |
Luisa Novellino, Riccardo L. Rossi, Ferruccio Bonino, Daniela Cavallone, Sergio Abrignani, Massimiliano Pagani, Maurizia R. Brunetto, Wang-Shick Ryu. Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs. PLoS ONE 2012; 7(3): e31952 doi: 10.1371/journal.pone.0031952
|
| 44 |
Bo Liu, Xin Wen, Canhua Huang, Yuquan Wei. Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years. The International Journal of Biochemistry & Cell Biology 2013; 45(9): 1987 doi: 10.1016/j.biocel.2013.06.017
|
| 45 |
Hikmet Akkiz. The Emerging Role of MicroRNAs in
Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology 2014; 4(1): 45 doi: 10.5005/jp-journals-10018-1095
|
| 46 |
Tomohisa Yoneyama, Takehisa Ueno, Kazunori Masahata, Chiyoshi Toyama, Akira Maeda, Yuko Tazuke, Takaharu Oue, Shuji Miyagawa, Hiroomi Okuyama. Elevation of microRNA-214 is associated with progression of liver fibrosis in patients with biliary atresia. Pediatric Surgery International 2022; 38(1): 115 doi: 10.1007/s00383-021-05009-7
|
| 47 |
Anna Emilia Kern, Gregor Ortmayr, Alice Assinger, Patrick Starlinger. The role of microRNAs in the different phases of liver regeneration. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 959 doi: 10.1080/17474124.2023.2267422
|
| 48 |
William W Du, Fengqiong Liu, Sze Wan Shan, Xindi Cindy Ma, Shaan Gupta, Tianru Jin, David Spaner, Sergey N Krylov, Yaou Zhang, Wenhua Ling, Burton B Yang. Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels. Molecular Therapy 2015; 23(7): 1222 doi: 10.1038/mt.2015.64
|
| 49 |
Ji Young Kim, Kyu Min Kim, Ji Hye Yang, Sam Seok Cho, Seung Jung Kim, Su Jung Park, Sang‐Gun Ahn, Gum Hwa Lee, Jin Won Yang, Sung Chul Lim, Keon Wook Kang, Sung Hwan Ki. Induction of E6AP by microRNA-302c dysregulation inhibits TGF-β-dependent fibrogenesis in hepatic stellate cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57322-w
|
| 50 |
|
| 51 |
Jinbao Wang, Qingjuan Tan, Weishan Wang, Jie Yu. <p>Mechanism of the Regulatory Effect of Overexpression of circMTO1 on Proliferation and Apoptosis of Hepatoma Cells via miR-9-5p/NOX4 Axis</p>. Cancer Management and Research 2020; : 3915 doi: 10.2147/CMAR.S240719
|
| 52 |
Dongkyun Kim, Jinsoo Song, Chihyun Ahn, Yeonho Kang, Churl-Hong Chun, Eun-Jung Jin. Peroxisomal dysfunction is associated with up-regulation of apoptotic cell death via miR-223 induction in knee osteoarthritis patients with type 2 diabetes mellitus. Bone 2014; 64: 124 doi: 10.1016/j.bone.2014.04.001
|
| 53 |
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 755 doi: 10.1007/978-94-007-7675-3_37
|
| 54 |
David E. Amacher. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014; 19(7): 541 doi: 10.3109/1354750X.2014.958535
|
| 55 |
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
|
| 56 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24): 3959 doi: 10.3390/cells11243959
|
| 57 |
|
| 58 |
Tünde Halász, Gábor Horváth, Gabriella Pár, Klára Werling, András Kiss, Zsuzsa Schaff, Gábor Lendvai. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. World Journal of Gastroenterology 2015; 21(25): 7814-7823 doi: 10.3748/wjg.v21.i25.7814
|
| 59 |
Sara Ceccarelli, Nadia Panera, Daniela Gnani, Valerio Nobili. Dual Role of MicroRNAs in NAFLD. International Journal of Molecular Sciences 2013; 14(4): 8437 doi: 10.3390/ijms14048437
|
| 60 |
Ruijie Gong, Xiaofei Lv, Fengqiong Liu. MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1. Cellular & Molecular Biology Letters 2018; 23(1) doi: 10.1186/s11658-018-0083-3
|
| 61 |
Jie Li, Xiaoyun Zhu, Meihui Zhang, Yanqiu Zhang, Shengtao Ye, Yingrong Leng, Ting Yang, Lingyi Kong, Hao Zhang. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. Journal of Hepatology 2021; 75(2): 400 doi: 10.1016/j.jhep.2021.02.035
|
| 62 |
Monika Kwiecinski, Natalia Elfimova, Andrea Noetel, Ulrich Töx, Hans-Michael Steffen, Ulrich Hacker, Roswitha Nischt, Hans Peter Dienes, Margarete Odenthal. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Laboratory Investigation 2012; 92(7): 978 doi: 10.1038/labinvest.2012.70
|
| 63 |
Shervi Lie, Janna L. Morrison, Olivia Williams-Wyss, Catherine M. Suter, David T. Humphreys, Susan E. Ozanne, Song Zhang, Severence M. MacLaughlin, David O. Kleemann, Simon K. Walker, Claire T. Roberts, I. Caroline McMillen. Impact of maternal undernutrition around the time of conception on factors regulating hepatic lipid metabolism and microRNAs in singleton and twin fetuses. American Journal of Physiology-Endocrinology and Metabolism 2016; 310(2): E148 doi: 10.1152/ajpendo.00600.2014
|
| 64 |
Yu-Jun Zhang, Ying Hu, Jing Li, Yu-Jing Chi, Wei-Wei Jiang, Feng Zhang, Yu-Lan Liu. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. Hepatobiliary & Pancreatic Diseases International 2017; 16(1): 65 doi: 10.1016/S1499-3872(16)60098-X
|
| 65 |
Yemiao Chen, Catherine M. Verfaillie. MicroRNAs: the fine modulators of liver development and function. Liver International 2014; 34(7): 976 doi: 10.1111/liv.12496
|
| 66 |
Wiebke Werner, Hannes Sallmon, Annekatrin Leder, Steffen Lippert, Anja Reutzel-Selke, Mehmet Haluk Morgül, Sven Jonas, Christof Dame, Peter Neuhaus, John Iacomini, Stefan G Tullius, Igor M Sauer, Nathanael Raschzok. Independent effects of sham laparotomy and anesthesia on hepatic microRNA expression in rats. BMC Research Notes 2014; 7(1) doi: 10.1186/1756-0500-7-702
|
| 67 |
Tie‑Zheng Wang, Dong‑Dong Lin, Bo‑Xun Jin, Xiang‑Ying Sun, Ning Li. Plasma microRNA: A novel non‑invasive biomarker for HBV‑associated liver fibrosis staging. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7117
|
| 68 |
Ashley M. Lakner, Nury M. Steuerwald, Tracy L. Walling, Sriparna Ghosh, Ting Li, Iain H. McKillop, Mark W. Russo, Herbert L. Bonkovsky, Laura W. Schrum. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 2012; 56(1): 300 doi: 10.1002/hep.25613
|
| 69 |
Gabor Lendvai, Katalin Jármay, Gizella Karácsony, Tünde Halász, Ilona Kovalszky, Kornélia Baghy, Tibor Wittmann, Zsuzsa Schaff, András Kiss. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World Journal of Gastroenterology 2014; 20(41): 15343-15350 doi: 10.3748/wjg.v20.i41.15343
|
| 70 |
Kaifeng Chu, Jie Gu. microRNA-103a-3p promotes inflammation and fibrosis in nonalcoholic fatty liver disease by targeting HBP1. Immunopharmacology and Immunotoxicology 2022; 44(6): 993 doi: 10.1080/08923973.2022.2102988
|